(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AVANCE CLINICAL THE CRO FOR BIOTECHS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AVANCE CLINICAL THE CRO FOR BIOTECHS

ST13

US500000079401298

Class

35, 42

Filing

79401298

Registration

7988932

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

07/24/2026

Trademark type

Word

Nice classes

35, 42

Filing date

05/24/2024

Registration date

10/21/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/21/2025

Last transaction

07/24/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

AU

Examiner

LAVACHE, LINDA M

Law office

L60

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Avance Clinical Pty Ltd

Representatives

David L. May Nixon Peabody LLP

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business statistical analysis; business statistical studies; compilation of statistics for business purposes; data collection for biotechnology and pharmaceutical companies for business purposes; data compilation for others for business purposes; data management servicesbusiness information management services for use by biotechnology and pharmaceutical companies for business purposes; data management adviceproviding advice in the field of business information management; data management consultancyconsultancy in the field of business information management; data processing servicesdatabase management; data capturecomputer data entry services; data cleansing servicescomputer data entry services in the nature of correcting or removing inaccurate or incomplete data from databases; Data processing servicesupdating and maintenance of data in computer databases; Data processing servicesdata systemization in computer databases; data processing; data processing verification; Data processing servicesdata retrieval; Data processing servicesdata transcriptioncomputer data entry services; demand-based computerised data processing

Class 42

Advisory services relating to pharmacology; advisory services relating to product testing; advisory services relating to science in the field of pharmacology; advisory services relating to scientific research; development of software systems for the processing of data; development of testing methods in the field of pharmacology; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of pharmacology; conducting technical project studiesconducting scientific feasibility studies in the field of pharmacology; consultancy pertaining to pharmacology; medical research; pharmaceutical research services; preparation of reports relating to scientific research; preparation of statistics for scientific researchpreparation of technical reports and analyses of statistical data for scientific research; provision of information relating to scientific research; Product quality testing; research relating to biotechnology; scientific research relating to data processing; research relating to medicine; research relating to pharmaceuticals; scientific and technical analysis in the field of pharmacology; scientific consultancy services relating to pharmacology; scientific testing services in the field of pharmacology; pharmaceutical testing services for assessing the efficiency of pharmaceuticals; pharmaceutical testing services for assessing the safety of pharmaceuticals; technical data analysis services in the field of pharmacology for scientific research purposes; testing of products

Publications

History of USPTO decisions and trademark events.

34 publications found

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/23/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/28/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/07/2026

FIMP

FINAL DISPOSITION PROCESSED

05/07/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/21/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/15/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/31/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

12/31/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/21/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/21/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/02/2025

PUBO

PUBLISHED FOR OPPOSITION

09/02/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/27/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/28/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

07/28/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/28/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

07/28/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/28/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/29/2025

GNFR

FINAL REFUSAL E-MAILED

05/29/2025

CNFR

FINAL REFUSAL WRITTEN

05/29/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/06/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/06/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/06/2025

RFNT

REFUSAL PROCESSED BY IB

01/25/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/04/2025

RFRR

REFUSAL PROCESSED BY MPU

01/04/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/17/2024

CNRT

NON-FINAL ACTION WRITTEN

12/16/2024

DOCK

ASSIGNED TO EXAMINER

12/09/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

09/13/2024

MAFR

APPLICATION FILING RECEIPT MAILED

08/06/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/06/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/01/2024

Continuous trademark protection

Get notified about every new filing that threatens AVANCE CLINICAL THE CRO FOR BIOTECHS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.